| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |